http://finance.yahoo.com/news/JampJ-wins-US-approval-for-apf-3173064825.html?x=0&.v=5 may sound the death knell for Lovenox. Oral, more efficacy, equal side effects, same price...I think I could sell it!
Ahhhh, yes. I am so focused on sales forces being disseminated that I wasn't thinking about the ripple effect of that...